(Q52217192)

27 April 2018

title

Speech and language deficits in early-treated children with galactosemia. (English)

1 reference

27 April 2018

0 references

Waisbren SE

1

1 reference

27 April 2018

Norman TR

series ordinal

2

1 reference

27 April 2018

Schnell RR

series ordinal

3

1 reference

27 April 2018

Levy HL

series ordinal

4

1 reference

27 April 2018

language of work or name

English

0 references

publication date

1 January 1983

1 reference

27 April 2018

The Journal of Pediatrics

published in

1 reference

27 April 2018

volume

102

1 reference

27 April 2018

issue

1

1 reference

27 April 2018

page(s)

75-77

1 reference

27 April 2018

Newborn screening for galactosemia and other galactose metabolic defects

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980292-3

Long-term Follow-up of Galactosaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980292-3

Unusual late neurological sequelae in galactosaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980292-3

Evidence for galactosaemia in utero

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980292-3

Hypogonadism and galactosemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980292-3

The prevalence of language delay in a population of three-year-old children and its association with general retardation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980292-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(83)80292-3

1 reference

27 April 2018

PubMed ID

6848731

1 reference

27 April 2018